Background: The objectives of this study were to investigate the predictive
Introduction
Preoperative radiochemotherapy (PRCT) is now considered a standard treatment for patients diagnosed with locally advanced rectal cancer (LARC). A significant tumor downsizing and downstaging, as well as a reduction of the risk for local recurrence and longer survival have been observed as a result of PRCT (1) (2) (3) . Within this context, 18 F-FDG PET imaging has been demonstrated as an interesting predictive tool (4) . Indeed, correlations between the pathological tumor response after PRCT and the SUV decrease within the tumor have been demonstrated in several studies (5) (6) (7) (8) (9) . In most of these studies, the SUV evolution between the baseline PET scan and the one acquired before surgery was correlated with the tumor regression grade (TRG) (5) (6) (7) (8) (9) . However, allowing for earlier prediction of the response is of higher interest for the clinical practice, since it might enable modifications of the treatment protocol (10) . A few studies have investigated the early prediction of the pathological tumor response based on 18 F-FDG PET imaging during PRCT (8) (9) . Cascini et al. showed that changes in the metabolic activity of the tumor, measured as early as 15 days after the start of PRCT, were predictive for response (8) . More recently, Janssen et al. have examined three different time points of 18 F-FDG PET imaging during PRCT, in order to define the optimal time for early prediction (9) . In this study 18 F-FDG PET scans at baseline, as well as at 8 and 15 days during PRCT were carried out and it was found that the best predictive factor of TRG was the SUV max response index (RI, defined as the percent evolution relative to the pretreatment value) at 15 days. All these studies have considered SUV measurements (max and/or mean) only. It has been demonstrated recently in several studies and various malignancies that other 18 F-FDG PET derived parameters more fully characterizing tumors on a functional level can have statistically higher predictive value than SUV hal-00749296, version 1 -7 Nov 2012 (10) (11) (12) (13) (14) (15) (16) (17) . These include metabolically active tumor volume (MATV, defined as the tumor volume as it can be seen and delineated on a PET image) (11) and total lesion glycolysis (TLG, multiplying MATV and its associated mean SUV) (12) . In addition, some of these studies demonstrated that response could be predicted by extracting these parameters from the pretreatment scan only, therefore potentially eliminating or reducing the need for sequential scans during treatment. Such results have been presented within the context of locally advanced esophageal cancer (LAEC) (11, 13) , non-Hodgkin lymphoma (14) , pleural mesothelioma (15) and cervix and head & neck cancers (16), whereas conflicting results have been recently obtained in rectal cancer (17) (18) . Finally, most of these studies have considered the evolution of PET derived parameters without partial volume effects (PVE) correction (PVC). This may lead to biased results especially if MATVs change size and/or shape during treatment. The current study was therefore conducted retrospectively on the cohort previously imaged (9) with the following objectives: 1) determine the predictive value of baseline 18 F-FDG PET derived parameters, 2) investigate the evolution of these parameters during treatment and their associated predictive value, and 3) investigate the impact of PVC on these results.
MATERIAL AND METHODS

Patients
This study consisted of a retrospective analysis of a cohort of 28 patients (see table   1 ) diagnosed with nonmetastasized LARC previously recruited in a prospective imaging study (9) approved by the medical ethics committee and for which all patients gave written informed consent before entering the study. Although all tumors may not strictly speaking be considered as locally advanced according to staging, hal-00749296, version 1 -7 Nov 2012 none of the patients could be resected immediately because of the high risks of differentiation, bulkiness, and size en location of the tumor. They were therefore all treated with the same PCRT protocol as recommended for LARC patients. All patients underwent PRCT (28 fractions of 1.8 Gy, 5 fractions a week, and concomitant capecitabine, 825 mg/m 2 , twice a day), followed by surgery (total mesorectal excision). Patients underwent 18 F-FDG PET/CT scans at baseline, and on days 8 and 15 of treatment. From here onwards, these scans will be denoted as PET i , with i from 1 to 3.
18
F-FDG PET/CT acquisitions
The protocol was designed to ensure robust SUV measurements across all three time points. Patients received an intravenous injection of FDG after a minimal fasting period of 6 hours, with the activity normalized for the weight of the patient as follows: 
Pathological tumor response grade (TRG)
The ground-truth of tumor response to therapy was determined in histology since all patients underwent total mesorectal excision. 
Partial volume effects correction
All PET images were corrected for PVE using an iterative deconvolution method previously validated on simulated and clinical datasets (20) . This approach iteratively estimates the corrected voxels values through Lucy-Richardson deconvolution (21-
22)
with prior knowledge (within ±1mm, as it has been shown that a 1mm error in the PSF led to a negligible impact on measured SUVs (23)) of the scanner's Point Spread Function (PSF), assumed to be spatially invariant in the field of view. In this study the tumors were all in the exact same body region and this assumption has therefore no significant impact on the applied correction on a patient-by-patient comparison basis. Wavelet-based denoising was incorporated using Bayeshrink filtering (24) , applied to the residual within each iteration of the deconvolution process. This allows using a sufficient number of iterations to correct for PVE without significant noise addition. This methodology is voxel-based and therefore does not assume homogeneous regional radiotracer distributions for the tumor and/or surrounding background.
Investigated parameters and analysis
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All parameters were extracted from the original (PET 1-3 ) and PVE corrected (PET 1- ). TLG was determined by multiplying the MATV and its associated SUV mean .
Response indices (RIs) corresponding to one (RI 2 ) and two (RI 3 ) weeks were calculated as the percentage evolution with respect to the baseline value (PET 1 ) as follows: RI n =(param n -param 1 )/param 1 ×100 for n=2 and 3. Similarly, RI 2-3 PVC were calculated using the parameters extracted from PET 1-3 PVC images.
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Statistical analysis
Statistical analyses were performed using Medcalc TM (MedCalc Software, Belgium).
All quantitative values were expressed as means ± standard deviations (SD) and ranges (minimum -maximum). Binary response status based on TRG classification
(1-2 vs. 3-5) was correlated with baseline values (param 1 ) as well as RI 2-3 for early sequential scans (PET 2-3 ) using a Mann-Whitney U test. For the parameters that were found to be significantly correlated with response, the predictive performance regarding the identification of nonresponders was evaluated using ROC analysis.
Area under the curve (AUC), along with the best compromise between sensitivity and specificity were reported, as well as results associated with a specificity of 100%, corresponding to the clinical goal of identifying nonresponders without erroneously identifying any of the responders. For RI [2] [3] , only cut-off values above +30% or below -30% were considered. This constraint was applied because the reproducibility (or test-retest assessment) of the PET derived parameters (both SUV and volume-based measurements) under investigation here has been previously determined to be at such upper and lower limits (27) . Thus characterization of response (or disease progression) based on evolution of PET derived indices must take into account such reproducibility limits. All tests were two-sided and p values below 0.05 were considered statistically significant.
RESULTS
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Statistics for baseline and evolution of all derived parameters (with or without PVC) are given in Regarding ROC analysis, AUCs and associated optimal sensitivities/specificities with PVC were mostly similar as without correction. For SUV mean1 PVC , AUC increased from 0.75 to 0.76, although it led to a reduced sensitivity (44% instead of 50%) with the same specificity of 100% (figure 2A).
Evolution of parameters during PRCT and associated predictive value
Without PVC
There was a global trend to decreasing MATV and associated uptake of the tumors during PRCT across the cohort of patients, with further reduction at 15 days (table 2) .
However, these PET parameters were also found to be increasing for some patients ( According to ROCs analysis, RI 2 s of neither SUV mean nor TLG (the only two parameters for which there was a statistical difference at 8 days between responders and nonresponders) allowed satisfactory prediction of TRG. With an AUC of 0.73, the optimal cut-off value above 30% change (-31%) for SUV mean was associated with a sensitivity of 88% but a specificity of only 33%. RI 2 of TLG led to an AUC of 0.75 and much lower sensitivity (56%) but higher specificity (67%) with a cut-off value of -34%.
At 8 days, 100% specificity could be achieved only using too low cut-off values (-10% only for SUV mean , and -23% for TLG) and at the cost of reduced sensitivity for SUV mean (50%).
Predictive performance improved at 15 days with higher sensitivities/specificities for all parameters. For SUV max , a -43% RI 3 cut-off value was associated with 88% sensitivity and 58% specificity, whereas a -34% RI 3 for SUV mean led to 81% sensitivity and 67% specificity. Reduction of TLG using a RI 3 cut-off value of -53% led to lower sensitivity (63%) but higher specificity (92%) (figure 2B). At 15 days, maximizing specificity was associated with low RI 3 cut-off values (-11 and -16% for SUV mean and SUV max ), except for TLG for which the cut-off value was -37%, with however a hal-00749296, version 1 -7 Nov 2012 sensitivity of only 38%. Sensitivities associated with 100% specificity were also between 30 and 40% for the other parameters.
With PVC
Evolution of the parameters after 8 and 15 days was not significantly altered by PVC, with very similar values of RIs for all parameters (see table 2 ). PVC had therefore no impact on the statistical difference between RIs of responders and nonresponders.
After correction, the RI 2 s still did not allow statistical differentiation between responders and nonresponders for most parameters, except for TLG and SUV mean which was already the case without PVC. Similarly, all the RI 3 s except MATV were still able to statistically differentiate the nonresponders from the responders after PVC, but the differentiation was significantly neither improved nor reduced.
Similarly, ROCs results were not significantly altered by PVC, although AUCs varied by up to ±0.05. Sensitivities and specificities corresponding to optimal cut-off values on the other hand were in a few cases significantly modified. For example, the sensitivity associated with RI 3 of SUV max was decreased after PVC from 88 to 50%, with an increase of specificity from 58 to 83%. Similar changes were observed for the other parameters at both 8 and 15 days, without nonetheless significantly reduce or increase the predictive performance of the parameters.
DISCUSSION
Neither the predictive value of baseline PET images nor the one of PET features demonstrated that the reduction of SUV max after 2 weeks was a good predictor of response, but they did not investigate other PET parameters beyond SUV mean or their baseline predictive value (9) . None of these studies investigated the impact of PVC.
To the best of our knowledge, the current study is the first investigation on a homogeneous LARC cohort including the impact of PVC, four PET derived parameters (SUV max , SUV mean , MATV, TLG), and three (baseline and after 1 and 2 weeks) 18 F-FDG PET scans during PCRT.
On the one hand, contrary to results in LAEC (10), neither the baseline MATV nor the derived TLG were significantly associated with response. On the other hand, some of the baseline parameters were of predictive value, such as higher SUV mean being associated with responding tumors (p=0.02), and allowed prediction of the nonresponders with a specificity of 100% but a limited sensitivity of 50%. A similar trend was observed with SUV max , although without reaching statistical significance (p=0.06).
Overall, response was associated with higher decrease of the SUV mean and TLG were significantly correlated with TRG. Second, an important constraint was that cut-off values of RI 2-3 s had to be larger than ±30%, because of the upper and lower reproducibility limits of such PET derived measurements (27) .
However, measured RI 2-3 s were often within this range, especially after one week, although it was still the case even after two weeks. This may constitutes one of the major limitations of early PET based response prediction, and the reproducibility of PET acquisitions clearly need to be improved in that regard. On the one hand, according to ROCs analysis, the reduction of SUV mean after 2 weeks was associated with an AUC of 0.79, a 100% specificity and 31% sensitivity associated with a RI 2 cut-off value of -11%, which is too low with regard to the reproducibility limits, as it is the case for all other parameters. The only exception was TLG: a -37% RI 3 cut-off value led to 100% specificity and 38% sensitivity, whereas a -53% cut-off value led to the best compromise of 63% sensitivity and 92% specificity.
Usually, higher SUVs are associated with more aggressive tumors, and therefore may be potentially more resistant. However according to our results, responding tumors were found to have higher initial SUVs. This can be associated with the fact that they were also the ones exhibiting the highest uptake decrease during treatment.
In addition, the tumors that were classified as nonresponders based on the RI 3 of TLG (specificity 100%, sensitivity 38%) are almost the same as those classified as nonresponders based on their baseline mean SUVs (specificity 100%, sensitivity 50%). Therefore waiting for 2 weeks did not significantly (p>0.05) improve prediction of response in this context when maximizing specificity, despite increased overall AUCs, which is a new result with respect to previous findings that only investigated the predictive value of RIs and not absolute baseline values (9) .
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The classification could be further improved using logistic regression of several parameters such as baseline MATV and SUV mean values and their evolution at 8 and 15 days, resulting in an AUC of 0.88, with a sensitivity and specificity of 88% and 83% respectively, whereas a specificity of 100% was associated with 50% sensitivity ( figure 2C ). Similar results were obtained with PVC (AUC 0.92, 92% specificity and 81% sensitivity, 56% sensitivity associated with 100% specificity). However, such weighted model combining more than one parameter on 28 patients only is likely to be over fitted to the data and would require validation on a larger cohort.
Regarding PVC, despite significant impact on the absolute values (except for MATV), it had limited impact on the predictive value of the parameters. Similar results regarding the impact of PVC on baseline predictive value were obtained for baseline prediction of chemoradiotherapy response in LAEC (28) . This is the first study however investigating the PVC impact on the predictive value of sequential scans.
This lack of impact may be explained by the fact that although the tumor volumes significantly shrinked during the first two weeks of PCRT (-36±29% after 2 weeks), their volume were still large (mean 36cm order to validate our preliminary results. Finally, the TRG classification, although it constitutes the best measurement of tumor response available, was determined by one pathologist only.
CONCLUSION
Our results in this preliminary study suggest that early prediction of tumor response to PRCT in rectal cancer using sequential 18 F-FDG PET scans is challenging due to limited reproducibility of PET imaging, especially after one week that was found to be suboptimal in both robustness due to small evolutions of the parameters and accuracy with no correlation with response. The best compromise between accuracy and robustness of prediction was obtained by considering the reduction of total lesion glycolysis after two weeks of PCRT, with a sensitivity of 63%
and specificity of 92%, although the improvement over baseline absolute mean SUV prediction (specificity 100%, sensitivity 50%) was not significant. Table 3 hal-00749296, version 1 -7 Nov 2012 hal-00749296, version 1 -7 Nov 2012 Figure 2C hal-00749296, version 1 -7 Nov 2012 
